GEMI vs INCY · rev $179.6M vs P/E 14, rev $5.14B
Gemini Space Station, Inc. Class A Common Stock (GEMI) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Gemini Space Station, Inc. Class A Common Stock (GEMI) is a capital markets company listed on NASDAQ.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported GEMI revenue for 2025-12-31 was $179.6M. Net income was -$582.8M. Revenue was up 26.3% from 2024-12-31 to 2025-12-31. GEMI currently screens at market cap $630.9M.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
GEMI currently screens at market cap $630.9M. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the GEMI and INCY stock pages for the full models.
Not investment advice.